At Dana-Farber/Brigham and Women's Cancer Center, your health and safety, along with the health and safety of our staff, are our top priorities. As our cancer specialists continue to learn more about the rapidly evolving COVID-19 (2019 Novel Coronavirus) pandemic, we want to keep our new and existing cancer patients informed. Visit our COVID-19 FAQ: For Cancer Patients for answers to some of the common questions cancer patients and caregivers are asking about COVID-19.
In this video, "Patient-Centered Cancer Care During COVID-19", Dr. Daphne Haas-Kogan, chair of the Department of Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center, shares the many safety measures implemented to ensure hundreds of cancer patients continue to receive cutting-edge, cancer care during COVID-19.
Dana-Farber/Brigham and Women's Cancer Center has a singular focus on conquering cancer and improving the way that cancer care is delivered throughout the world. Through our 12 specialized disease treatment centers, experts from one of the world's leading cancer institutes and one of the world's leading hospitals work together as one team to offer the most advanced treatments with the compassion and care that makes all the difference.
Dana-Farber/Brigham and Women’s Cancer Center has a quick access program that provides for appointments with an oncologist as soon as the next day for newly-diagnosed adult patients.
Precision Cancer Medicine focuses on a patient’s disease at a genetic level and seeks to find targeted treatments for each individual’s cancer
Search ongoing clinical trials for cancer at Dana-Farber and affiliated institutions, and learn what it means to participate in a clinical trial.
U.S. News & World Report ranks Dana-Farber/Brigham and Women’s Cancer Center #4 in the nation 2021-2022.
The EDDC conducts research dedicated to studying new drugs that might become safe and effective treatments for cancer.
The Adult Survivorship Program provides expertise, education and support to help manage issues related to surviving cancer.
The CIO conducts clinical studies in unleashing the power of the body's immune system to detect and combat tumors.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.